Frazier Healthcare Partners

Profile

Frazier Healthcare Partners is a prominent private equity investor headquartered in Seattle, with a specific focus on the healthcare sector. Founded over 33 years ago, the firm is supported by a robust team of over 99 professionals who bring deep industry expertise and networks. Frazier Healthcare is known for its Executive in Residence program and its strategic focus on high-conviction investment themes, which allows them to pair with proven executives to create value in their portfolio companies.

The firm targets investments in various aspects of healthcare, including biotechnology, medical devices, healthcare services, and pharmaceuticals. Frazier Healthcare Partners tends to focus on platform investments with an emphasis on buy-and-build strategies, supporting companies through acquisitions, with over 47 platform investments and more than 179 acquisitions completed. They primarily invest in North American companies and focus on growth-stage investments, though specific check size and stages are not disclosed. Their substantial experience in the healthcare domain is backed by a deep network that plays a significant role in operational and human capital development within their portfolio.

Notable investments by Frazier Healthcare Partners include companies like Parata - a pharmacy automation solutions provider, AirLife - a respiratory healthcare company, and United Digestive - a gastrointestinal care provider. These investments highlight their commitment to fostering growth in diverse areas within the healthcare sector, leveraging their extensive industry knowledge and strategic partnerships.